Search research articles
Contact Us
Filters
Showing results (511-520 of 529) with videos related to
Page
of 53
Sort By:
Annals of Human Genetics
|
August 14, 2002
Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease
S Popat, N Hearle, L Hogberg, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
September 10, 2005
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, et al.
Cancer Research
|
February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor
Bo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.
Gates Open Research
|
August 18, 2020
Reduced dengue incidence following deployments of <i>Wolbachia</i>-infected <i>Aedes aegypti</i> in Yogyakarta, Indonesia: a quasi-experimental trial using controlled interrupted time series analysis
Citra Indriani, Warsito Tantowijoyo, Edwige Rancès, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
Ping Liu, Linus S Lin, Terence G Hamill, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2007
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists
Helen E Armstrong, Amy Galka, Linus S Lin, et al.
Plos Neglected Tropical Diseases
|
November 30, 2023
Reduced dengue incidence following city-wide wMel Wolbachia mosquito releases throughout three Colombian cities: Interrupted time series analysis and a prospective case-control study
Ivan Dario Velez, Stephanie K Tanamas, Maria Patricia Arbelaez, et al.
Journal of Medicinal Chemistry
|
December 22, 2006
Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity
Linus S Lin, Thomas J Lanza, James P Jewell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents
Tung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
Page
of 53
Search research articles
Search
Showing results (511-520 of 529) with videos related to
Sort By:
Page
of 53
Annals of Human Genetics
|
August 14, 2002
Variation in the CTLA4/CD28 gene region confers an increased risk of coeliac disease
S Popat, N Hearle, L Hogberg, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|
September 10, 2005
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S Silverberg, Jack Satsangi, Tariq Ahmad, et al.
Cancer Research
|
February 11, 2010
MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor
Bo-Sheng Pan, Grace K Y Chan, Melissa Chenard, et al.
Gates Open Research
|
August 18, 2020
Reduced dengue incidence following deployments of <i>Wolbachia</i>-infected <i>Aedes aegypti</i> in Yogyakarta, Indonesia: a quasi-experimental trial using controlled interrupted time series analysis
Citra Indriani, Warsito Tantowijoyo, Edwige Rancès, et al.
Journal of Medicinal Chemistry
|
July 5, 2007
Discovery of N-{(1S,2S)-2-(3-cyanophenyl)- 3-[4-(2-[18F]fluoroethoxy)phenyl]-1-methylpropyl}- 2-methyl-2-[(5-methylpyridin-2-yl)oxy]propanamide, a cannabinoid-1 receptor positron emission tomography tracer suitable for clinical use
Ping Liu, Linus S Lin, Terence G Hamill, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 13, 2007
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists
Helen E Armstrong, Amy Galka, Linus S Lin, et al.
Plos Neglected Tropical Diseases
|
November 30, 2023
Reduced dengue incidence following city-wide wMel Wolbachia mosquito releases throughout three Colombian cities: Interrupted time series analysis and a prospective case-control study
Ivan Dario Velez, Stephanie K Tanamas, Maria Patricia Arbelaez, et al.
Journal of Medicinal Chemistry
|
December 22, 2006
Discovery of N-[(1S,2S)-3-(4-Chlorophenyl)-2- (3-cyanophenyl)-1-methylpropyl]-2-methyl-2- {[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), a novel, acyclic cannabinoid-1 receptor inverse agonist for the treatment of obesity
Linus S Lin, Thomas J Lanza, James P Jewell, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
March 1, 2007
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents
Tung M Fong, Xiao-Ming Guan, Donald J Marsh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2007
[18F]MK-9470, a positron emission tomography (PET) tracer for in vivo human PET brain imaging of the cannabinoid-1 receptor
H Donald Burns, Koen Van Laere, Sandra Sanabria-Bohórquez, et al.
Page
of 53